3-hydroxy-2-phenyl-4(1H)-quinolinones as promising biologically active compounds

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 6, 2009, Pages 696-702

  Hradil, P ^a   Hlavac J ^a   Soural, M ^a   Hajduch M ^a   Kolar M ^a   Vecerova R ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Antibacterial activity; Anticancer activity; Inhibition; Quinolinones

Indexed keywords

2 (3,4 DIHYDROXYPHENYL) 3 HYDROXY 5,7 DIFLUORO 4(1H) QUINOLINONE; 3 HYDROXY 2 PHENYL 4(1H) QUINOLINONE 7 CARBOXYLIC ACID; 3 HYDROXY 2 PHENYL 4(1H) QUINOLINONE DERIVATIVE; 3,5,7 TRIHYDROXY 2 PHENYL 4(1H) QUINOLINONE 7 CARBOXYLIC ACID; 5,7 DICHLOROQUINOLINONE; 6,8 DICHLOROQUINOLINONE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); QUINOLINOL DERIVATIVE; UNCLASSIFIED DRUG; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CYTOTOXICITY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; IMMUNOREGULATION; NONHUMAN; REVIEW; BACTERIUM; CHEMISTRY; DRUG EFFECT; IC 50; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 69249229665     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788452720     Document Type: Review

References (27)

1. Sword, I. P. Reaction of 2,3-epoxy-3-(2-nitrophenyl)propiophenone (2-nitrochalcone epoxide) with hydrogen chloride. J. Chem. Soc. Sect C., 1971, 5, 820-823.
2. Spence, T. W. M.; Tennant, G. Chemistry of nitro compounds. I. Acid-catalyzed ring-opening reactions of substituted (onitrophenyl) ethylene oxides involving participation by the nitro group. J. Chem. Soc. Sect. C., 1971, 22, 3712-3719.
3. Venturella, P.; Bellino.A.; Piozzi, F.; Marino, M. L. Synthesis of quinoline alkaloids. VIII. The synthesis of japonine. Heterocycles, 1976, 4, 1089-1094.
4. Velezheva V.S., Mel'man A.I., Pol'shakov V.I.; Asimova O.S. A novel synthesis of 2-aryl-3-hydroxy(alkoxy)-4-quinolones by expanding the ring of 1-acetyl-2-(arylmethylene)-3-indolines. Khim. Geter. Soed., 1992, 2, 279-280.
5. Behrman J.E.; Kiser L.R.; Garas W.F.; Behrman E.C.; Pitt B.M. Conversion of 4-quinolones into 3-hydroxy-4-quinolones via the corresponding sulfates. J. Chem. Res., Synop., 1995, 5, 164-165.
6. Hradil, P.; Jirman, J. Synthesis of 2-aryl-3-hydroxyquinolin-4(1H)-ones. Collect. Czech. Chem. Commun., 1995, 60, 1357-1366.
7. Hradil P., Hlaváĉ J., Lemr K.: Preparation of 1,2-disubstituted-3-hydroxy-4(1H)-quinolinones and the influence of substitution on the course of cyclization. J. Heterocyclic Chem., 1999, 36, 141-144.
8. Spáĉilová L., Hlaváĉ J., Hradil P. Hajduch M., Krejĉí P. Synthesis of N-amino-3-hydroxy-2-phenyl-4(1H)-quinolinone. J. Heterocyclic. Chem., 2006, 43, 1065-1070.
9. Yeleswarapu, K.R.; Manojit, P.; Vedula M.S.; Akella, V.; Pillarisetti, S.; Padakanti, S.; Kalleda, S.R. Preparation of heterocyclic compounds including chromenones, quinazolinones, quinolinones and pyrazolopyrimidinone that block the effects of advanced glycation end products. WO2005040163 (Reddy's Laboratories Ltd., India). CAS: 142:447230.
10. Yushchenko, D.A.; Bilokin', M.D.; Pyvovarenko, O. V.; Duportail, G.; Mely, Y.; Pivovarenko, V.G. Synthesis and fluorescence properties of 2-aryl-3-hydroxyquinolones, a new class of dyes displaying dual fluorescence. Tetrahedron Lett., 2006, 47, 905-908.
11. Heravi, M.M.; Oskooie, H.A.; Bahrami, L.; Ghassemzadeh, M. Solid-state induced heterocyclization under microwave irradiation: synthesis of 2-phenyl-3-hydroxyquinolin-4(1H)-one. Indian J. Chem., Sect. B, 2006, 45B, 779-781.
12. Soural, M.; Krchnak, V. Efficient Solid-Phase Synthesis of 2-Substituted-3-Hydroxy-4(1H)-Quinolinone-7-Carboxamides with Two Diversity Positions. J. Comb. Chem., 2007, 9, 793-796.
13. Rao, Y.K.; Pal, M.; Sharma, V.M.; Venkateswarlu, A.; Pillarisetti, R. Preparation of chromenones, quinolones, and related compounds as modulators of inflammatory responses such as those resulting from AGE and glycated protein accumulation. WO2005042712 (Reddy US Therapeutics, Inc., USA). CAS: 142:463715.
14. Tamura, T.; Kuriyama, H.; Agoh, M.; Agoh, Y.; Soga, M.; Mori, T. Preparation of 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds as antiviral agents. EP1380575 (Maruishi Pharmaceutical Co., Ltd., Japan); CAS: 140:93939.
15. Gao, F.; Johnson K.F.; Schlenoff J.B. Ring closing and photooxidation in nitrogen analogs of 3-hydroxyflavone. J. Chem. Soc., Perkin Trans., 2, 1996, 269-273.
16. Sui Z. Nguyen, V.N.; Altom, J.; Fernandez, J.; Hilliard, J.J.; Bernstein, J.I.; Barrett, J.F.; Ohemeng, K.A. Synthesis and topoisomerase inhibitory activities of novel aza-analogues of flavones. Eur. J. Med. Chem. 1999, 34, 381-387.
17. Hradil, P.; Kvapil, L.; Hlaváĉ, J.; Weidlich T.; Lyĉka, A. Preparation of 2-phenyl-2-hydroxymethyl-4-oxo-1,2,3,4-tetrahydroquinazoline and 2-methyl-4-oxo-3,4-dihydroquinazoline derivatives. J. Heterocyclic Chem., 2000, 37, 831-837.
18. Ulubelen, A.; Terem, B.; Tuzlaci, E.; Cheng, K. F.; Kong, Y. C. Phytochemistry, 1986, 25, 2692-2693.
19. Noskova, V.; Dzubak, P.; Kuzmina, G.; Ludkova, A.; Stehlik, D.; Trojanec, R.; Janostakova, A.; Korinkova, G.; Mihal, V.; Hajduch, M. In vitro chemoresistance profile and expression/function of MDR associated proteins in resistant cell lines derived from CCRF-CEM, K562, A549 and MDA MB 231 parental cells. Neoplasma, 2002, 49, 418-425;
20. b) Sarek, J.; Klinot, J.; Dzubak, P.; Klinotova, E.; Noskova, V.; Krecek, V.; Korinkova, G.; Thomson, J. O.; Janost'akova, A.; Wang, S.; Parsons, S.; Fischer, P.M; Zhelev, N.Z; Hajduch, M. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structureactivity relationships. J. Med. Chem., 2003, 46, 5402-5415;
21. c) Dzubak, P.; Hajduch, M.; Vydra, D.; Hustova, A.; Kvasnica, M.; Biedermann, D.; Markova, L.; Urban, M.; Sarek, J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep., 2006, 23, 394-411.
22. Soural, M.; Hlaváĉ, J.; Hradil, P.; Fryŝová, I.; Hajdúch, M.; Bertolasi, V.; Malon̂, M. Synthesis and cytotoxic activity of substituted 2-phenyl-3-hydroxy-4(1H)-quinolinones-7-carboxylic acids and their phenacyl esters. Eur. J. Med. Chem., 2006, 41, 467-474.
23. Krejĉí P.; Hradil P.; Hlaváĉ J.; Hajdúch M. Preparation of 2-phenyl-3-hydroxyquinolin-4(1H)-ones for treatment of immune system and proliferative disorders. WO2008028427 (University of Palacky); CAS: 148:331570.
24. Rajeshwar P. V. Understanding topoisomerase I and II in terms of QSAR. Bioorg. Med. Chem., 2005, 13, 1059-1067.
25. Iwanowicz, E.J.; Watterson, S.H.; Dhar, T. G. M.; Pitts, W. J.; Gu, H. H. Preparation of 6-(5-oxazolyl)-4(1H)-quinolinones as inhibitors of IMPDH enzyme. WO2001081340 (Bristol-Myers Squibb Company, USA); CAS: 135:344472.
26. Cimino, G.; De Rosa, S.; De Stefano, S.; Spinella, A.; Sodano, G. The zoochrome of the sponge Verongia aerophoba ("uranidine"). Tetrahedron Lett., 1984, 25, 2925-2928.
27. Loya, S.; Rudi, A.; Tal, R.; Kashman, Y.; Loya, Y.; Hizi, A. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. Arch. Biochem. Biophys., 1994, 309, 315-322.